Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  American Heart Journal

• Publication date

  1993-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-8703(93)90702-BPMID 8213445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors.

  1992cited by this paper
• Furosemide‐Induced Natriuresis Is Augmented by Ultra‐Low‐Dose Captopril but Not by Standard Doses of Captopril in Chronic Heart Failure

  1992cited by this paper
• Neuroendocrine changes post myocardial infarction: effects of xamoterol.

  1990cited by this paper
• Interference of different ACE-inhibitors with the diuretic action of furosemide and hydrochlorothiazide

  1989cited by this paper
• Evidence for a proximal and distal nephron action of atrial natriuretic factor in man.

  1989cited by this paper
• Biological variation of urinary N-acetyl-beta-D-glucosaminidase: practical and clinical implications.

  1989cited by this paper
• Captopril and the diuretic requirements in moderate and severe chronic heart failure.

  1989cited by this paper
• Renal hemodynamic consequences of angiotensin-converting enzyme inhibition in congestive heart failure.

  1989cited by this paper
• Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.

  1988cited by this paper
• The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.

  1988cited by this paper
• Effects of angiotensin II and atrial natriuretic peptide alone and in combination on urinary water and electrolyte excretion in man.

  1988cited by this paper
• The effect of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man.

  1988cited by this paper
• Acute hemodynamic, hormonal and electrolyte effects of ramipril in severe congestive heart failure.

  1987cited by this paper
• Absence of a pharmacokinetic interaction between enalapril and frusemide.

  1987cited by this paper
• Inhibition of renal clearance of furosemide by pentopril, an angiotensin—converting enzyme inhibitor

  1987cited by this paper
• Eicosapentaenoic acid: its relevance in atherosclerosis and coronary artery disease.

  1987cited by this paper
• Comparison of captopril and enalapril in patients with severe chronic heart failure.

  1986cited by this paper
• Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.

  1986cited by this paper
• Atrial natriuretic factor: structure and functional properties.

  1985cited by this paper
• Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.

  1984cited by this paper
• Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.

  1984cited by this paper
• Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man.

  1984cited by this paper
• Captopril in heart failure. A double blind controlled trial.

  1984cited by this paper
• A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.

  1983cited by this paper
• Effects of atrial natriuretic factor on renal handling of water and electrolytes in rats.

  1983cited by this paper
• Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins.

  1983cited by this paper
• The effects of captopril on the acute vascular responses to frusemide in man.

  1983cited by this paper
• Effect of captopril on renal function in patients with congestive heart failure.

  1981cited by this paper
• Release of vasoactive materials from the kidney by diuretics.

  1977cited by this paper

• How to prescribe loop diuretics in oedema

  2019cites this paper
• Use of Diuretics in the Treatment of Heart Failure in Older Adults.

  2017cites this paper
• Everything we always wanted to know about furosemide but were afraid to ask.

  2016cites this paper
• PREVALENCE, CLINICAL IMPORTANCE AND PREDICTORS OF POTENTIAL DRUG-DRUG INTERACTIONS IN DIFFERENT WARDS OF TERTIARY CARE HOSPITAL SETTING

  2012cites this paper
• Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study

  2011cites this paper
• for Chapter 11 Diuretic Therapy in Cardiovascular Disease

  2011cites this paper
• Prevalence, types and predictors of potential drug-drug interactions in pulmonology ward of a tertiary care hospital

  2011cites this paper
• Interacciones de drogas anti-hipertensivas

  2008cites this paper
• Use of diuretics in the treatment of heart failure in the elderly.

  2007cites this paper
• Use of diuretics in the treatment of heart failure in the elderly.

  2007cites this paper
• Acute decompensated heart failure: formulating an evidence-based approach to diagnosis and treatment (part I).

  2006cites this paper
• Acute decompensated heart failure: formulating an evidence-based approach to diagnosis and treatment (part II).

  2006cites this paper
• Antihypertensive therapy: special focus on drug interactions

  2003cites this paper
• Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.

  2003cites this paper
• antihipertensivos. Interés de sus interacciones con otros fármacos en atención primaria

  2002cites this paper
• Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association.

  2001cites this paper
• Pharmacology and pharmacotherapy of cardiovascular drugs in patients with chronic renal disease.

  2001cites this paper
• The choice of first-line therapy: rationale for low-dose combinations of an angiotensin converting enzyme inhibitor and a diuretic.

  2001cites this paper
• Striking Increase of Natriuresis by Low-Dose Spironolactone in Congestive Heart Failure Only in Combination With ACE Inhibition: Mechanistic Evidence to Support RALES

  2000cites this paper
• [Renin-angiotensin-aldosterone system inhibition: pharmacologic rationale and evaluations of drug combinations].

  1998cites this paper
• Congested states: is there a price for confounding cardiac and renal failure?

  1998cites this paper
• Increased toxicity of high‐dose furosemide versus low‐dose dopamine in the treatment of refractory congestive heart failure

  1997cites this paper
• [Treatment of cardiac failure with angiotensin-converting enzyme inhibitors and diuretics].

  1996cites this paper
• Influence of ACE Inhibition on Fluid Metabolism in Chronic Heart Failure and Its Pathophysiologic Relevance

  1996cites this paper
• Heart failure: Lessons learned over the past 25 years

  1995cites this paper
• The renin angiotensin aldosterone system and frusemide response in congestive heart failure.

  1995cites this paper
• Which diuretic to use?

  1994cites this paper